In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031

1 INTRODUCTION 60 1.1 STUDY OBJECTIVES 60 1.2 MARKET DEFINITION 60 1.3 MARKET SCOPE 61 1.3.1 MARKETS COVERED 61 1.3.2 INCLUSIONS & EXCLUSIONS 62 1.3.3 YEARS CONSIDERED 63 1.3.4 CURRENCY CONSIDERED 63 1.4 STAKEHOLDERS 63 2 EXECUTIVE SUMMARY 64 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 64 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 65 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 66 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 67 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 68 3 PREMIUM INSIGHTS 69 3.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW 69 3.2 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE 70 3.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 71 3.4 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET SHARE, BY END USER, 2026 VS 2031 (%) 71 4 MARKET OVERVIEW 72 4.1 INTRODUCTION 72 4.2 MARKET DYNAMICS 72 4.2.1 DRIVERS 74 4.2.1.1 Growing Industry Shift Toward Non-Animal Toxicology Testing Methods 74 4.2.1.2 Increasing Technological Advancements 74 4.2.1.3 Rising Pharmaceutical R&D Expenditure and Drug Attrition Costs 74 4.2.2 RESTRAINTS 75 4.2.2.1 Limited In Vivo-to-In Vitro Correlation for Complex Endpoints 75 4.2.2.2 High Cost of Advanced Platforms (Organ-on-Chip, 3D Models) 75 4.2.3 OPPORTUNITIES 75 4.2.3.1 AI/ML-Powered Predictive Toxicology 75 4.2.3.2 Increasing Focus on Drug Discovery Using In Vitro Methods 76 4.2.3.3 Cannabis, E-Cigarette, and Novel Product Safety Testing 76 4.2.4 CHALLENGES 76 4.2.4.1 Ethical and Regulatory Challenges in AI-Driven Toxicology 76 4.3 UNMET NEEDS AND WHITE SPACES 77 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 77 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 77 5 INDUSTRY TRENDS 79 5.1 PORTER’S FIVE FORCES ANALYSIS 79 5.1.1 THREAT OF NEW ENTRANTS 80 5.1.2 THREAT OF SUBSTITUTES 80 5.1.3 BARGAINING POWER OF BUYERS 80 5.1.4 BARGAINING POWER OF SUPPLIERS 80 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 80 5.2 MACROECONOMIC OUTLOOK 81 5.2.1 INTRODUCTION 81 5.2.2 GDP TRENDS AND FORECAST 81 5.2.3 TRENDS IN GLOBAL IN VITRO TOXICOLOGY TESTING MARKET 81 5.3 VALUE CHAIN ANALYSIS 82 5.4 ECOSYSTEM ANALYSIS 83 5.5 PRICING ANALYSIS 85 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2025 86 5.5.2 INDICATIVE SELLING PRICE, BY REGION, 2025 86 5.6 KEY CONFERENCES & EVENTS 87 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 87 5.8 INVESTMENT/FUNDING ACTIVITY 88 5.9 IMPACT OF 2025 TARIFFS—IN VITRO TOXICOLOGY TESTING MARKET 89 5.9.1 INTRODUCTION 89 5.9.2 KEY TARIFF RATES 89 5.9.3 PRICE IMPACT ANALYSIS 90 5.9.4 IMPACT ON COUNTRIES/REGIONS 90 5.9.4.1 North America 90 5.9.4.2 Europe 91 5.9.4.3 Asia Pacific 91 5.9.5 IMPACT ON END-USE INDUSTRIES 91 5.9.5.1 Pharmaceutical and biotechnology companies 92 5.9.5.2 CROs 92 5.9.5.3 Academic & Research Institutes 92 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 93 6.1 KEY TECHNOLOGIES 93 6.1.1 CELL CULTURE TECHNOLOGIES 93 6.1.2 OMICS TECHNOLOGIES 93 6.2 ADJACENT TECHNOLOGIES 94 6.2.1 COMPUTATIONAL TOXICOLOGY AND AI 94 6.3 COMPLEMENTARY TECHNOLOGIES 94 6.3.1 LAB-ON-A-CHIP (LOC)/ORGAN-ON-A-CHIP (OOC) SYSTEMS 94 6.4 TECHNOLOGY/PRODUCT ROADMAP 95 6.5 PATENT ANALYSIS 95 6.5.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR IN VITRO TOXICOLOGY TESTING PATENTS, 2015–2025 96 6.6 FUTURE APPLICATIONS 97 6.7 IMPACT OF AI/GEN AI ON IN VITRO TOXICOLOGY TESTING MARKET 97 6.7.1 TOP USE CASES AND MARKET POTENTIAL 98 6.7.2 CASE STUDIES OF AI IMPLEMENTATION IN IN VITRO TOXICOLOGY TESTING MARKET 99 6.7.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 99 6.7.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN IN VITRO TOXICOLOGY TESTING MARKET 99 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 102 7.1 REGIONAL REGULATIONS AND COMPLIANCE 102 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 7.1.2 REGULATORY FRAMEWORK 105 7.1.3 INDUSTRY STANDARDS 106 7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 107 7.3 CERTIFICATIONS, LABELING, & ECO-STANDARDS 108 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 110 8.1 DECISION-MAKING PROCESS 110 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 110 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 110 8.2.2 KEY BUYING CRITERIA, BY END USER 111 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 112 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 113 8.5 MARKET PROFITABILITY 113 9 IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING 114 9.1 INTRODUCTION 115 9.2 PRODUCTS 115 9.2.1 GROWING ADOPTION OF ADVANCED ASSAY PRODUCTS TO SUPPORT GROWTH 115 9.3 SERVICES 119 9.3.1 INCREASING FOCUS ON OUTSOURCING TOXICOLOGY TO AID GROWTH 119 10 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE 123 10.1 INTRODUCTION 124 10.2 REAGENTS & CONSUMABLES 124 10.2.1 CULTURE REAGENTS, MEDIA, AND CONSUMABLES 127 10.2.1.1 Increasing adoption of IVTT workflows and recurring use of reagents to support growth 127 10.2.2 3D MODELS & TISSUE SYSTEMS 131 10.2.2.1 Support from regulatory agencies and wide usage to drive market growth 131 10.2.3 CELL LINES & PRIMARY CELLS 134 10.2.3.1 Emphasis on personalized medicine and driving quality improvement in commercially available cells to propel market 134 10.2.4 OTHER REAGENTS & CONSUMABLES 137 10.3 ASSAY KITS 140 10.3.1 ORGAN-SPECIFIC TOXICITY ASSAYS 143 10.3.1.1 Market is driven well-documented failure of generic cytotoxicity screens to predict organ-level adverse effects 143 10.3.2 CYTOTOXICITY ASSAYS 146 10.3.2.1 Cytotoxicity assays are the most universally applied assays in IVTT 146 10.3.3 GENOTOXICITY ASSAYS 149 10.3.3.1 Stringent regulatory mandates to support growth 149 10.3.4 OTHER ASSAYS 152 10.4 EQUIPMENT 155 10.4.1 DETECTION, IMAGING, AND ANALYTICAL SYSTEMS 158 10.4.1.1 Detection instruments 161 10.4.1.1.1 Growth is supported by the increasing volume of HTS workflows in pharmaceutical R&D and expanding use of functional safety pharmacology assays 161 10.4.1.2 Imaging systems 164 10.4.1.2.1 Demand for imaging systems in IVTT is being driven by the transition from single-endpoint to multiparametric, image-based toxicity assessment 164 10.4.1.3 Other instruments 168 10.4.1.4 Liquid handling & automation systems 171 10.4.1.4.1 Ease offered by automation and the important role of liquid handling in workflow to aid growth 171 10.4.1.5 Other instruments 174 10.5 SOFTWARE & INFORMATICS 177 10.5.1 DEMAND FOR AI/ML CAPABILITIES WITH TOXICOLOGY DATA TO DRIVE GROWTH 177 11 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST 181 11.1 INTRODUCTION 182 11.2 ORGAN TOXICITY TESTING 182 11.2.1 HEPATOTOXICITY 185 11.2.1.1 Regulatory mandates and focus on developing advanced liver models to support growth 185 11.2.2 OCULAR TOXICITY 189 11.2.2.1 Demand for cosmetics application to aid growth 189 11.2.3 CARDIOTOXICITY 192 11.2.3.1 Regulatory imperative for comprehensive cardiac safety profiling to drive growth 192 11.2.4 NEUROTOXICITY 195 11.2.4.1 Focus on developmental neurotoxicity and the expanding CNS drug pipelines to support growth 195 11.2.5 OTHER TOXICITY END POINTS 198 11.3 CYTOTOXICITY TESTING 201 11.3.1 A GROWING NUMBER OF NEW CLINICAL ENTITIES AND THE EXPANSION OF HTS PROGRAMS DRIVES MARKET 201 11.4 DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION 204 11.4.1 RISING AWARENESS AND BAN ON ANIMAL TESTING TO PROPEL MARKET 204 11.5 GENOTOXICITY TESTING 207 11.5.1 MANDATORY REQUIREMENT IN DRUG APPLICATIONS SUPPORTS MARKET GROWTH 207 11.6 OXIDATIVE STRESS AND MECHANISTIC TOXICITY 210 11.6.1 SHIFT TOWARD MECHANISTIC UNDERSTANDING TO DRIVE DEMAND FOR ASSAYS 210 11.7 OTHER TOXICITY ENDPOINTS & TESTS 213 12 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY 216 12.1 INTRODUCTION 217 12.2 CELL CULTURE TECHNOLOGIES 217 12.2.1 ADVANCING ADOPTION OF HUMAN-RELEVANT CELL CULTURE MODELS TO SUPPORT MARKET GROWTH 217 12.3 HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES 220 12.3.1 EXPANDING HIGH-THROUGHPUT TOXICITY SCREENING TO ACCELERATE EARLY SAFETY ASSESSMENT 220 12.4 ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES 223 12.4.1 GROWING FOCUS ON HUMAN-RELEVANT TOXICITY PREDICTION TO SUPPORT GROWTH 223 12.5 OMICS TECHNOLOGIES 226 12.5.1 INCREASING INTEGRATION OF OMICS-BASED TOXICOLOGY TO IMPROVE MECHANISTIC RISK ASSESSMENT 226 12.6 OTHER TECHNOLOGIES 229 13 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD 232 13.1 INTRODUCTION 233 13.2 CELL-BASED TOXICITY TESTING 233 13.2.1 CELL-BASED TOXICITY TESTING HOLDS LARGEST MARKET SHARE 233 13.3 BIOCHEMICAL TOXICITY TESTING METHOD 237 13.3.1 SPEED AND REPRODUCIBILITY TO AID GROWTH 237 13.4 MOLECULAR & OMICS-BASED TOXICOLOGY METHOD 240 13.4.1 TRANSITION FROM SINGLE-ENDPOINT TO SYSTEMS-LEVEL TOXICOLOGICAL ASSESSMENT DRIVES DEMAND GROWTH 240 13.5 EX VIVO MODEL-BASED TOXICITY TESTING METHOD 243 13.5.1 INCREASING AVAILABILITY OF HUMAN DONOR TISSUE TO SUPPORT ADOPTION 243 13.6 IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD 247 13.6.1 ESCALATING COST AND TIME PRESSURES OF PHYSICAL TESTING TO AID GROWTH 247 13.7 OTHER METHODS 250 14 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER 253 14.1 INTRODUCTION 254 14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 254 14.2.1 RISING GLOBAL PHARMACEUTICAL R&D EXPENDITURE SUPPORTING DRUG DISCOVERY EFFORTS 254 14.3 CONSUMER CARE COMPANIES 258 14.3.1 ANIMAL TESTING BANS TO SUPPORT SEGMENT GROWTH 258 14.4 CROS 261 14.4.1 HIGH CAPITAL AND OPERATIONAL COSTS OF MAINTAINING ADVANCED TECHNOLOGIES SUPPORT OUTSOURCING TO CROS 261 14.5 ACADEMIC & RESEARCH INSTITUTES 265 14.5.1 INCREASING GOVERNMENT FUNDING FOR ALTERNATIVE TESTING RESEARCH TO AID GROWTH 265 14.6 FOOD & BEVERAGE COMPANIES 268 14.6.1 GROWTH OF FUNCTIONAL FOODS, PLANT-BASED PROTEINS, AND NOVEL INGREDIENTS DRIVES DEMAND FOR TESTING 268 14.7 OTHER END USERS 272 15 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE 276 15.1 INTRODUCTION 277 15.2 TOXICOLOGY TESTING SERVICES 277 15.2.1 ORGAN-SPECIFIC TOXICITY SERVICES 280 15.2.1.1 High reliance on outsourced services and growing demand for cardiotoxicity testing to drive market 280 15.2.2 CYTOTOXICITY TESTING SERVICES 283 15.2.2.1 Growing preclinical pipelines requiring cytotoxicity testing to propel demand 283 15.2.3 GENOTOXICITY TESTING SERVICES 286 15.2.3.1 Expanding impurity testing obligations to drive market 286 15.2.4 OTHER TOXICITY TESTING SERVICES 289 15.3 BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES 292 15.3.1 STRONG GROWTH SUPPORTED BY RISING DEMAND FOR APPLICATION-SPECIFIC MODELS AND ASSAYS 292 15.4 IMAGING & ANALYTICAL TOXICOLOGY SERVICES 295 15.4.1 CAPITAL-INTENSIVE INSTRUMENTATION AND SPECIALIZED REQUIREMENTS SUPPORT OUTSOURCING 295 15.5 DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY 298 15.5.1 INTEGRATION OF AI/ML AND RISING DATA COMPLEXITY PROPEL DEMAND 298 16 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD 302 16.1 INTRODUCTION 303 16.2 CELL-BASED TOXICITY TESTING SERVICES 303 16.2.1 HIGH COST AND COMPLEXITY OF MAINTAINING ADVANCED CELL CULTURE INFRASTRUCTURE TO DRIVE GROWTH 303 16.3 BIOCHEMICAL TOXICITY TESTING SERVICES 307 16.3.1 GROWTH OF BIOLOGIC DRUG DEVELOPMENT IS DRIVING DEMAND FOR SPECIALIZED BIOCHEMICAL IMMUNOGENICITY TESTING SERVICES 307 16.4 IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES 310 16.4.1 GROWING DATA COMPLEXITY, AI/ML MATURITY, AND REGULATORY ACCEPTANCE DRIVE GROWTH 310 16.5 MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES 313 16.5.1 SPECIALIZED ANALYTICAL EXPERTISE REQUIREMENTS RELATED TO OMICS TO DRIVE GROWTH 313 16.6 EX VIVO MODEL-BASED TOXICITY TESTING SERVICES 317 16.6.1 USE OF EX VIVO MODELS FOR IN VITRO AND IN SILICO VALIDATION TO SUPPORT GROWTH 317 16.7 OTHER SERVICES 320 17 IN VITRO TOXICOLOGY TESTING SERVICE MARKET, BY END USER 323 17.1 INTRODUCTION 324 17.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 324 17.2.1 INCREASING COST AND COMPLEXITY OF MAINTAINING ADVANCED IVTT PLATFORMS IN-HOUSE TO SUPPORT GROWTH 324 17.3 CONSUMER CARE COMPANIES 328 17.3.1 REGULATION MANDATING IN VITRO-ONLY SAFETY ASSESSMENT IS SUPPORTING GROWTH 328 17.4 FOOD & BEVERAGE COMPANIES 331 17.4.1 EXPANDING SCOPE OF FUNCTIONAL FOOD AND ALTERNATIVE PROTEIN SAFETY ASSESSMENT TO SUPPORT GROWTH 331 17.5 ACADEMIC & RESEARCH INSTITUTES 335 17.5.1 OUTSOURCING OF SPECIALIZED SERVICES TO SUPPORT GROWTH 335 17.6 OTHER END USERS 338 18 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION 342 18.1 INTRODUCTION 343 18.2 NORTH AMERICA 343 18.2.1 US 351 18.2.1.1 Growing focus on biomarker discovery and research in structure-based drug design to propel the market 351 18.2.2 CANADA 359 18.2.2.1 Strong support for R&D in pharmaceuticals and proteomics to boost market growth 359 18.3 EUROPE 367 18.3.1 GERMANY 374 18.3.1.1 Well-established pharmaceuticals industry to support market growth 374 18.3.2 UK 382 18.3.2.1 Rising focus on research activities and academia-industry partnerships to drive market 382 18.3.3 FRANCE 390 18.3.3.1 Increasing government funding for proteomics and genomics research to drive market 390 18.3.4 ITALY 398 18.3.4.1 Increasing life sciences research to propel market 398 18.3.5 SPAIN 405 18.3.5.1 Growing chemicals industry to support market growth 405 18.3.6 REST OF EUROPE 413 18.4 ASIA PACIFIC 420 18.4.1 CHINA 429 18.4.1.1 Increasing international pressure to ban animal testing methods to propel the market 429 18.4.2 JAPAN 436 18.4.2.1 Rising demand for technologically advanced research products to drive market 436 18.4.3 INDIA 443 18.4.3.1 Growing focus of universities on avoiding animal testing for cosmetic products to propel the market 443 18.4.4 SOUTH KOREA 451 18.4.4.1 Growing government focus on boosting pharmaceutical spending to propel market growth 451 18.4.5 AUSTRALIA 458 18.4.5.1 Growing pharmaceutical research to help market growth 458 18.4.6 REST OF ASIA PACIFIC 464 18.5 LATIN AMERICA 471 18.5.1 BRAZIL 479 18.5.1.1 Adoption of non-animal testing methods to propel market 479 18.5.2 MEXICO 486 18.5.2.1 Ban on animal testing for cosmetics to support market growth 486 18.5.3 REST OF LATIN AMERICA 493 18.6 MIDDLE EAST 500 18.6.1 GCC COUNTRIES 507 18.6.1.1 Saudi Arabia 515 18.6.1.1.1 Rising pharmaceutical R&D activities and regulatory focus on alternative testing methods to support market growth 515 18.6.1.2 United Arab Emirates (UAE) 522 18.6.1.2.1 Expanding biotechnology ecosystem and growing focus on advanced safety assessment technologies supporting market growth 522 18.6.1.3 Rest of GCC Countries 529 18.6.1.4 Rest of Middle East 536 18.6.2 AFRICA 543 18.6.2.1 Precision medicine initiatives to fuel market growth 543 19 COMPETITIVE LANDSCAPE 550 19.1 OVERVIEW 550 19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 550 19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET 550 19.3 REVENUE SHARE ANALYSIS 552 19.4 MARKET SHARE ANALYSIS 553 19.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 555 19.5.1 STARS 555 19.5.2 EMERGING LEADERS 555 19.5.3 PERVASIVE PLAYERS 556 19.5.4 PARTICIPANTS 556 19.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 557 19.5.5.1 Company footprint 557 19.5.5.2 Region footprint 558 19.5.5.3 Offering footprint 559 19.5.5.4 Technology footprint 560 19.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 561 19.6.1 PROGRESSIVE COMPANIES 561 19.6.2 STARTING BLOCKS 561 19.6.3 RESPONSIVE COMPANIES 561 19.6.4 DYNAMIC COMPANIES 561 19.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS 563 19.6.5.1 Competitive benchmarking of key startups/SMEs 564 19.7 COMPANY VALUATION & FINANCIAL METRICS 565 19.7.1 FINANCIAL METRICS 565 19.7.2 COMPANY VALUATION 565 19.8 BRAND/PRODUCT COMPARISON 566 19.9 COMPETITIVE SCENARIO 567 19.9.1 PRODUCT LAUNCHES 567 19.9.2 DEALS 568 19.9.3 EXPANSIONS 568 20 COMPANY PROFILES 569 20.1 THERMO FISHER SCIENTIFIC INC. 569 20.1.1 BUSINESS OVERVIEW 569 20.1.1.1 Products/Services/Solutions offered 570 20.1.1.2 Recent developments 574 20.1.1.2.1 Product launches 574 20.1.1.2.2 Deals 575 20.1.1.2.3 Expansions 575 20.1.1.3 MnM view 576 20.1.1.3.1 Key strengths 576 20.1.1.3.2 Strategic choices 576 20.1.1.3.3 Weaknesses and competitive threats 576 20.1.2 AGILENT TECHNOLOGIES, INC. 577 20.1.2.1 Business overview 577 20.1.2.2 Products/Services/Solutions offered 578 20.1.2.3 Recent developments 580 20.1.2.3.1 Product launches & enhancements 580 20.1.2.3.2 Deals 581 20.1.2.4 MnM view 581 20.1.2.4.1 Key strengths 581 20.1.2.4.2 Strategic choices 581 20.1.2.4.3 Weaknesses and competitive threats 581 20.1.3 MERCK KGAA 582 20.1.3.1 Business overview 582 20.1.3.2 Products/Services/Solutions offered 583 20.1.3.3 Recent developments 585 20.1.3.3.1 Deals 585 20.1.3.4 MnM view 585 20.1.3.4.1 Key strengths 585 20.1.3.4.2 Strategic choices 585 20.1.3.4.3 Weaknesses and competitive threats 585 20.1.4 EUROFINS SCIENTIFIC 586 20.1.4.1 Business overview 586 20.1.4.2 Products/Services/Solutions offered 587 20.1.4.3 Recent developments 594 20.1.4.3.1 Expansions 594 20.1.5 CHARLES RIVER LABORATORIES 595 20.1.5.1 Business overview 595 20.1.5.2 Products/Services/Solutions offered 596 20.1.5.3 Recent developments 600 20.1.5.3.1 Product launches 600 20.1.5.3.2 Deals 600 20.1.5.3.3 Other developments 601 20.1.5.4 MnM view 601 20.1.5.4.1 Key strengths 601 20.1.5.4.2 Strategic choices 601 20.1.5.4.3 Weaknesses and competitive threats 601 20.1.6 LABORATORY CORPORATION OF AMERICA HOLDINGS 602 20.1.6.1 Business overview 602 20.1.6.2 Products/Services/Solutions offered 603 20.1.6.3 Recent developments 606 20.1.6.3.1 Deals 606 20.1.6.3.2 Expansions 606 20.1.6.3.3 Other developments 607 20.1.6.4 MnM view 607 20.1.6.4.1 Key strengths 607 20.1.6.4.2 Strategic choices 607 20.1.6.4.3 Weaknesses and competitive threats 607 20.1.7 SGS SA 608 20.1.7.1 Business overview 608 20.1.7.2 Products/Services/Solutions offered 609 20.1.7.3 Recent developments 612 20.1.7.3.1 Deals 612 20.1.7.3.2 Expansions 612 20.1.8 LONZA 613 20.1.8.1 Business overview 613 20.1.8.2 Products/Services/Solutions offered 614 20.1.9 REVVITY 616 20.1.9.1 Business overview 616 20.1.9.2 Products/Services/Solutions offered 617 20.1.9.3 Recent developments 619 20.1.9.3.1 Product launches 619 20.1.9.3.2 Other developments 619 20.1.10 BIO-RAD LABORATORIES, INC. 620 20.1.10.1 Business overview 620 20.1.10.2 Products/Services/Solutions offered 621 20.1.10.3 Recent developments 623 20.1.10.3.1 Product launches 623 20.1.10.3.2 Deals 624 20.1.11 EVOTEC SE 625 20.1.11.1 Business overview 625 20.1.11.2 Products/Services/Solutions offered 626 20.1.11.3 Recent developments 633 20.1.11.3.1 Deals 633 20.1.11.3.2 Other developments 633 20.1.12 NOVO HOLDINGS 634 20.1.12.1 Business overview 634 20.1.12.2 Products & services offered 634 20.1.13 INTERTEK GROUP PLC 635 20.1.13.1 Business overview 635 20.1.13.2 Products & services offered 637 20.1.14 INOTIV 638 20.1.14.1 Business overview 638 20.1.14.2 Products & services offered 639 20.1.15 PROMEGA CORPORATION 642 20.1.15.1 Business overview 642 20.1.15.2 Products & services offered 642 20.1.15.3 Recent developments 645 20.1.15.3.1 Deals 645 20.2 OTHER PLAYERS 646 20.2.1 BIOIVT 646 20.2.2 CREATIVE BIOLABS 647 20.2.3 MEDICILON 648 20.2.4 CREATIVE BIOARRAY 649 20.2.5 ARAGEN LIFE SCIENCES LTD. 650 20.2.6 ENZO BIOCHEM INC. 652 20.2.7 MICROBAC LABORATORIES, INC. 655 20.2.8 VIMTA LABS LTD. 657 20.2.9 PACIFIC BIOLABS, INC. 658 20.2.10 MB RESEARCH LABORATORIES 659 21 RESEARCH METHODOLOGY 660 21.1 RESEARCH DATA 660 21.1.1 SECONDARY DATA 661 21.1.2 PRIMARY DATA 661 21.2 MARKET SIZE ESTIMATION 662 21.2.1 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET ESTIMATION, 2025 662 21.2.1.1 Key industry insights 666 21.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 667 21.4 MARKET BREAKDOWN AND DATA TRIANGULATION 670 21.5 RESEARCH ASSUMPTIONS 671 21.6 RESEARCH LIMITATIONS 672 21.7 RISK ANALYSIS 672 22 APPENDIX 673 22.1 DISCUSSION GUIDE 673 22.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 678 22.3 CUSTOMIZATION OPTIONS 680 22.4 RELATED REPORTS 680 22.5 AUTHOR DETAILS 681

TABLE 1 IN VITRO TOXICOLOGY TESTING MARKET: IMPACT ANALYSIS 73 TABLE 2 IN VITRO TOXICOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 80 TABLE 3 IN VITRO TOXICOLOGY TESTING MARKET: ROLE IN ECOSYSTEM 84 TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 86 TABLE 5 INDICATIVE SELLING PRICE, BY REGION, 2025 86 TABLE 6 IN VITRO TOXICOLOGY TESTING MARKET: KEY CONFERENCES & EVENTS, 2026–2027 87 TABLE 7 US-ADJUSTED RECIPROCAL TARIFF RATES 89 TABLE 8 INDICATIVE LIST OF PATENTS IN IN VITRO TOXICOLOGY TESTING MARKET, 2026 97 TABLE 9 CASE STUDIES OF AI IMPLEMENTATION IN IN VITRO TOXICOLOGY TESTING MARKET 99 TABLE 10 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN IN VITRO TOXICOLOGY TESTING MARKET 100 TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102 TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103 TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104 TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104 TABLE 15 COUNTRY-WISE REGULATORY SCENARIO FOR IN VITRO TOXICOLOGY TESTING PRODUCT & SERVICE PROVIDERS 105 TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 111 TABLE 17 KEY BUYING CRITERIA, BY END USER 111 TABLE 18 IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031(USD MILLION) 115 TABLE 19 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY REGION, 2024–2031(USD MILLION) 116 TABLE 20 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 116 TABLE 21 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 117 TABLE 22 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 117 TABLE 23 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 118 TABLE 24 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY REGION, 2024–2031(USD MILLION) 118 TABLE 25 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION) 118 TABLE 26 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031(USD MILLION) 120 TABLE 27 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION) 120 TABLE 28 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION) 121 TABLE 29 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION) 121 TABLE 30 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION) 122 TABLE 31 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031(USD MILLION) 122 TABLE 32 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION) 122 TABLE 33 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 34 IVTT REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 125 TABLE 35 NORTH AMERICA: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 36 EUROPE: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 37 ASIA PACIFIC: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 38 LATIN AMERICA: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 39 MIDDLE EAST: IVTT REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 126 TABLE 40 GCC COUNTRIES: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 41 IVTT REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 127 TABLE 42 CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 128 TABLE 43 NORTH AMERICA: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 44 EUROPE: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 45 ASIA PACIFIC: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 46 LATIN AMERICA: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 47 MIDDLE EAST: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 130 TABLE 48 GCC COUNTRIES: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 49 3D MODELS & TISSUE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 132 TABLE 50 NORTH AMERICA: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 51 EUROPE: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 52 ASIA PACIFIC: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 53 LATIN AMERICA: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 54 MIDDLE EAST: 3D MODELS & TISSUE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 55 GCC COUNTRIES: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 56 CELL LINES & PRIMARY CELLS MARKET, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 57 NORTH AMERICA: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 58 EUROPE: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 59 ASIA PACIFIC: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 60 LATIN AMERICA: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 61 MIDDLE EAST: CELL LINES & PRIMARY CELLS MARKET, BY REGION, 2024–2031 (USD MILLION) 136 TABLE 62 GCC COUNTRIES: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 63 OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 64 NORTH AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 65 EUROPE: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 66 ASIA PACIFIC: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 67 LATIN AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 68 MIDDLE EAST: OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 69 GCC COUNTRIES: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 70 IVTT ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 71 NORTH AMERICA: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 72 EUROPE: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 73 ASIA PACIFIC: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 74 LATIN AMERICA: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 75 MIDDLE EAST: IVTT ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 76 GCC COUNTRIES: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 77 IVTT ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 78 ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 79 NORTH AMERICA: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 80 EUROPE: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 81 ASIA PACIFIC: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 82 LATIN AMERICA: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 83 MIDDLE EAST: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 145 TABLE 84 GCC COUNTRIES: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 85 CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 86 NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 87 EUROPE: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 88 ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 89 LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 90 MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 148 TABLE 91 GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 92 GENOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 93 NORTH AMERICA: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 94 EUROPE: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 95 ASIA PACIFIC: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 96 LATIN AMERICA: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 97 MIDDLE EAST: GENOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 98 GCC COUNTRIES: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 99 OTHER ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 100 NORTH AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 101 EUROPE: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 102 ASIA PACIFIC: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 103 LATIN AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 104 MIDDLE EAST: OTHER ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 105 GCC COUNTRIES: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 106 IVTT EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 107 NORTH AMERICA: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 108 EUROPE: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 109 ASIA PACIFIC: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 110 LATIN AMERICA: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 111 MIDDLE EAST: IVTT EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 112 GCC COUNTRIES: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 113 IVTT EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 158 TABLE 114 DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 115 NORTH AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 116 EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 117 ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 118 LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 119 MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 120 GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 121 DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 122 DETECTION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 123 NORTH AMERICA: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 124 EUROPE: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 125 ASIA PACIFIC: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 126 LATIN AMERICA: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 127 MIDDLE EAST: DETECTION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 128 GCC COUNTRIES: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 129 IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 165 TABLE 130 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 131 EUROPE: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 132 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 133 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 134 MIDDLE EAST: IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 135 GCC COUNTRIES: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 136 OTHER INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 168 TABLE 137 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 138 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 139 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 140 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 141 MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 142 GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 143 LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 144 NORTH AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 145 EUROPE: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 146 ASIA PACIFIC: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 147 LATIN AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 148 MIDDLE EAST: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 173 TABLE 149 GCC COUNTRIES: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 150 OTHER INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 151 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 152 EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 153 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 154 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 155 MIDDLE EAST: OTHER EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 176 TABLE 156 GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 157 IVTT SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION) 178 TABLE 158 NORTH AMERICA: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 159 EUROPE: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 160 ASIA PACIFIC: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 161 LATIN AMERICA: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 162 MIDDLE EAST: IVTT SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 163 GCC COUNTRIES: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 164 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 182 TABLE 165 ORGAN TOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 183 TABLE 166 NORTH AMERICA: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 167 EUROPE: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 168 ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 169 LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 170 MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 171 GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 172 ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 173 HEPATOTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 174 NORTH AMERICA: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 175 EUROPE: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 176 ASIA PACIFIC: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 177 LATIN AMERICA: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 178 MIDDLE EAST: HEPATOTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 179 GCC COUNTRIES: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 180 OCULAR TOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 189 TABLE 181 NORTH AMERICA: OCULAR TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 182 EUROPE: OCULAR TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 183 ASIA PACIFIC: OCULAR TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 184 LATIN AMERICA: OCULAR TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 185 MIDDLE EAST: OCULAR TOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 186 GCC COUNTRIES: OCULAR TOXICITY MARKET, BY COUNTRY , 2024–2031 (USD MILLION) 191 TABLE 187 CARDIOTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 188 NORTH AMERICA: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 189 EUROPE: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 190 ASIA PACIFIC: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 191 LATIN AMERICA: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 192 MIDDLE EAST: CARDIOTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 194 TABLE 193 GCC COUNTRIES: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 194 NEUROTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 195 NORTH AMERICA: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 196 EUROPE: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 197 ASIA PACIFIC: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 198 LATIN AMERICA: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 199 MIDDLE EAST: NEUROTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 197 TABLE 200 GCC COUNTRIES: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 201 OTHER TOXICITY END POINTS MARKET, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 202 NORTH AMERICA: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 203 EUROPE: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 204 ASIA PACIFIC: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 205 LATIN AMERICA: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 206 MIDDLE EAST: OTHER TOXICITY END POINTS MARKET, BY REGION, 2024–2031 (USD MILLION) 200 TABLE 207 GCC COUNTRIES: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 208 CYTOTOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 209 NORTH AMERICA: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 210 EUROPE: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 211 ASIA PACIFIC: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 212 LATIN AMERICA: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 213 MIDDLE EAST: CYTOTOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 203 TABLE 214 GCC COUNTRIES: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 215 DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY REGION, 2024–2031 (USD MILLION) 204 TABLE 216 NORTH AMERICA: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 217 EUROPE: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 218 ASIA PACIFIC: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 219 LATIN AMERICA: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 220 MIDDLE EAST: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY REGION, 2024–2031 (USD MILLION) 206 TABLE 221 GCC COUNTRIES: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 222 GENOTOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 223 NORTH AMERICA: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 224 EUROPE: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 225 ASIA PACIFIC: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 226 LATIN AMERICA: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 227 MIDDLE EAST: GENOTOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 209 TABLE 228 GCC COUNTRIES: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 229 OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 230 NORTH AMERICA: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 231 EUROPE: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 232 ASIA PACIFIC: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 233 LATIN AMERICA: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 234 MIDDLE EAST: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION) 212 TABLE 235 GCC COUNTRIES: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 236 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY REGION, 2024–2031 (USD MILLION) 213 TABLE 237 NORTH AMERICA: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 238 EUROPE: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 239 ASIA PACIFIC: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 240 LATIN AMERICA: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 241 MIDDLE EAST: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY REGION, 2024–2031 (USD MILLION) 215 TABLE 242 GCC COUNTRIES: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 243 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 217 TABLE 244 CELL CULTURE TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 218 TABLE 245 NORTH AMERICA: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 246 EUROPE: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 247 ASIA PACIFIC: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 248 LATIN AMERICA: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 249 MIDDLE EAST: CELL CULTURE TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 250 GCC COUNTRIES: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 251 HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 220 TABLE 252 NORTH AMERICA: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 253 EUROPE: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 254 ASIA PACIFIC: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 255 LATIN AMERICA: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 256 MIDDLE EAST: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 222 TABLE 257 GCC COUNTRIES: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 258 ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 223 TABLE 259 NORTH AMERICA: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 260 EUROPE: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 261 ASIA PACIFIC: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 225 TABLE 262 LATIN AMERICA: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 225 TABLE 263 MIDDLE EAST: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 264 GCC COUNTRIES: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 265 OMICS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 226 TABLE 266 NORTH AMERICA: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 267 EUROPE: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 268 ASIA PACIFIC: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 269 LATIN AMERICA: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 270 MIDDLE EAST: OMICS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 271 GCC COUNTRIES: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 229 TABLE 272 OTHER TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 229 TABLE 273 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 274 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 275 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 276 LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 277 MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 231 TABLE 278 GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 279 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 233 TABLE 280 CELL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 234 TABLE 281 NORTH AMERICA: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 282 EUROPE: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 283 ASIA PACIFIC: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 284 LATIN AMERICA: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 285 MIDDLE EAST: CELL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 236 TABLE 286 GCC COUNTRIES: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 287 BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 237 TABLE 288 NORTH AMERICA: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 289 EUROPE: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 290 ASIA PACIFIC: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 291 LATIN AMERICA: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 239 TABLE 292 MIDDLE EAST: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 239 TABLE 293 GCC COUNTRIES: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 239 TABLE 294 MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 240 TABLE 295 NORTH AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 296 EUROPE: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 297 ASIA PACIFIC: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 298 LATIN AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 299 MIDDLE EAST: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 242 TABLE 300 GCC COUNTRIES: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 301 EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 244 TABLE 302 NORTH AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 303 EUROPE: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 304 ASIA PACIFIC: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 305 LATIN AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 306 MIDDLE EAST: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 246 TABLE 307 GCC COUNTRIES: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 308 IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 247 TABLE 309 NORTH AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 310 EUROPE: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 311 ASIA PACIFIC: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 312 LATIN AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 313 MIDDLE EAST: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION) 249 TABLE 314 GCC COUNTRIES: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 315 OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 250 TABLE 316 NORTH AMERICA: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 250 TABLE 317 EUROPE: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 318 ASIA PACIFIC: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 319 LATIN AMERICA: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 320 MIDDLE EAST: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION) 252 TABLE 321 GCC COUNTRIES: OTHER METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 322 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 254 TABLE 323 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 255 TABLE 324 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 325 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 326 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 327 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 328 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 257 TABLE 329 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 330 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 258 TABLE 331 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 332 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 333 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 334 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 335 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 260 TABLE 336 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 337 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY REGION, 2024–2031 (USD MILLION) 262 TABLE 338 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 339 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 340 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 341 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 342 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY REGION, 2024–2031 (USD MILLION) 264 TABLE 343 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 344 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 265 TABLE 345 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 346 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 347 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 348 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 349 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 267 TABLE 350 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 351 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 269 TABLE 352 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 353 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 354 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 355 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 356 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 271 TABLE 357 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 358 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 272 TABLE 359 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 360 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 361 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 274 TABLE 362 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 274 TABLE 363 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 274 TABLE 364 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 365 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 366 TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 277 TABLE 367 NORTH AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 368 EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 369 ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 370 LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 371 MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 279 TABLE 372 GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 373 TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 374 ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 281 TABLE 375 NORTH AMERICA: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 376 EUROPE: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 377 ASIA PACIFIC: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 378 LATIN AMERICA: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 379 MIDDLE EAST: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 282 TABLE 380 GCC COUNTRIES: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 381 CYTOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 283 TABLE 382 NORTH AMERICA: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 383 EUROPE: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 384 ASIA PACIFIC: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 385 LATIN AMERICA: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 386 MIDDLE EAST: CYTOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 285 TABLE 387 GCC COUNTRIES: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 286 TABLE 388 GENOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 286 TABLE 389 NORTH AMERICA: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 287 TABLE 390 EUROPE: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 287 TABLE 391 ASIA PACIFIC: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 288 TABLE 392 LATIN AMERICA: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 288 TABLE 393 MIDDLE EAST: GENOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 288 TABLE 394 GCC COUNTRIES: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 395 OTHER TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 289 TABLE 396 NORTH AMERICA: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 397 EUROPE: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 398 ASIA PACIFIC: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 291 TABLE 399 LATIN AMERICA: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 291 TABLE 400 MIDDLE EAST: OTHER TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 291 TABLE 401 GCC COUNTRIES: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 402 BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 292 TABLE 403 NORTH AMERICA: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 404 EUROPE: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 405 ASIA PACIFIC: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 406 LATIN AMERICA: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 407 MIDDLE EAST: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 294 TABLE 408 GCC COUNTRIES: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 295 TABLE 409 IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 295 TABLE 410 NORTH AMERICA: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 411 EUROPE: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 412 ASIA PACIFIC: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 413 LATIN AMERICA: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 414 MIDDLE EAST: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 297 TABLE 415 GCC COUNTRIES: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 298 TABLE 416 DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 298 TABLE 417 NORTH AMERICA: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 299 TABLE 418 EUROPE: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 299 TABLE 419 ASIA PACIFIC: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 420 LATIN AMERICA: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 421 MIDDLE EAST: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 300 TABLE 422 GCC COUNTRIES: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 301 TABLE 423 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 303 TABLE 424 CELL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 304 TABLE 425 NORTH AMERICA: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 304 TABLE 426 EUROPE: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 427 ASIA PACIFIC: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 428 LATIN AMERICA: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 306 TABLE 429 MIDDLE EAST: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 306 TABLE 430 GCC COUNTRIES: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 306 TABLE 431 BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 307 TABLE 432 NORTH AMERICA: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 433 EUROPE: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 434 ASIA PACIFIC: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 309 TABLE 435 LATIN AMERICA: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 309 TABLE 436 MIDDLE EAST: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 309 TABLE 437 GCC COUNTRIES: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 310 TABLE 438 IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 310 TABLE 439 NORTH AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 311 TABLE 440 EUROPE: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 311 TABLE 441 ASIA PACIFIC: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 442 LATIN AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 443 MIDDLE EAST: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 312 TABLE 444 GCC COUNTRIES: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 445 MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 314 TABLE 446 NORTH AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 447 EUROPE: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315 TABLE 448 ASIA PACIFIC: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315 TABLE 449 LATIN AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 450 MIDDLE EAST: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 316 TABLE 451 GCC COUNTRIES: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 452 EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 317 TABLE 453 NORTH AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 454 EUROPE: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 318 TABLE 455 ASIA PACIFIC: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 318 TABLE 456 LATIN AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 457 MIDDLE EAST: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 319 TABLE 458 GCC COUNTRIES: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 459 OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 320 TABLE 460 NORTH AMERICA: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 320 TABLE 461 EUROPE: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 462 ASIA PACIFIC: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 463 LATIN AMERICA: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 322 TABLE 464 MIDDLE EAST: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 322 TABLE 465 GCC COUNTRIES: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 322 TABLE 466 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 324 TABLE 467 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 325 TABLE 468 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 325 TABLE 469 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 326 TABLE 470 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 326 TABLE 471 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 327 TABLE 472 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 327 TABLE 473 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 327 TABLE 474 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 328 TABLE 475 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 476 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 477 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 330 TABLE 478 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 330 TABLE 479 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 330 TABLE 480 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 331 TABLE 481 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 332 TABLE 482 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 332 TABLE 483 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 484 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 485 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 486 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 334 TABLE 487 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 488 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 335 TABLE 489 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 336 TABLE 490 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 336 TABLE 491 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 337 TABLE 492 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 337 TABLE 493 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 337 TABLE 494 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 338 TABLE 495 IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 339 TABLE 496 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 339 TABLE 497 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 498 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 499 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 341 TABLE 500 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 341 TABLE 501 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 341 TABLE 502 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 343 TABLE 503 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 504 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 345 TABLE 505 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 506 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 507 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 508 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 509 NORTH AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 346 TABLE 510 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 347 TABLE 511 NORTH AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 512 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 348 TABLE 513 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 348 TABLE 514 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 349 TABLE 515 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 516 NORTH AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 517 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 350 TABLE 518 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 351 TABLE 519 US: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 352 TABLE 520 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 521 US: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 522 US: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 523 US: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 524 US: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 525 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 355 TABLE 526 US: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 355 TABLE 527 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 356 TABLE 528 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 356 TABLE 529 US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 357 TABLE 530 US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 357 TABLE 531 US: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 358 TABLE 532 US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 358 TABLE 533 US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 359 TABLE 534 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 360 TABLE 535 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 536 CANADA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 360 TABLE 537 CANADA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 538 CANADA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 361 TABLE 539 CANADA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 540 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 362 TABLE 541 CANADA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 363 TABLE 542 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 363 TABLE 543 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 364 TABLE 544 CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 364 TABLE 545 CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 546 CANADA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 547 CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 366 TABLE 548 CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 366 TABLE 549 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 367 TABLE 550 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 367 TABLE 551 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 552 EUROPE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 553 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 554 EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 555 EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 556 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 370 TABLE 557 EUROPE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 558 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 371 TABLE 559 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 371 TABLE 560 EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 372 TABLE 561 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE , 2024–2031 (USD MILLION) 372 TABLE 562 EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 373 TABLE 563 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 373 TABLE 564 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 374 TABLE 565 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 375 TABLE 566 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 567 GERMANY: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 568 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 569 GERMANY: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 570 GERMANY: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 571 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 378 TABLE 572 GERMANY: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 573 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 379 TABLE 574 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 379 TABLE 575 GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 380 TABLE 576 GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 577 GERMANY: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 578 GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 381 TABLE 579 GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 382 TABLE 580 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 383 TABLE 581 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 383 TABLE 582 UK: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 583 UK: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 584 UK: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 585 UK: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 586 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 386 TABLE 587 UK: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 588 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 387 TABLE 589 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 387 TABLE 590 UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 388 TABLE 591 UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 592 UK: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 593 UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 389 TABLE 594 UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 390 TABLE 595 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 391 TABLE 596 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 597 FRANCE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 598 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 599 FRANCE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 600 FRANCE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 601 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 394 TABLE 602 FRANCE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 603 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 395 TABLE 604 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 395 TABLE 605 FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 396 TABLE 606 FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 607 FRANCE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 608 FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 397 TABLE 609 FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 398 TABLE 610 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 398 TABLE 611 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 612 ITALY: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 613 ITALY: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE , 2024–2031 (USD MILLION) 400 TABLE 614 ITALY: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 615 ITALY: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 616 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 401 TABLE 617 ITALY: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 618 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 402 TABLE 619 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 402 TABLE 620 ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 403 TABLE 621 ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 622 ITALY: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 623 ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 404 TABLE 624 ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 405 TABLE 625 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 406 TABLE 626 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 627 SPAIN: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 628 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 629 SPAIN: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 630 SPAIN: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 631 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 408 TABLE 632 SPAIN: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 633 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 409 TABLE 634 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 410 TABLE 635 SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 410 TABLE 636 SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 411 TABLE 637 SPAIN: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 411 TABLE 638 SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 412 TABLE 639 SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 412 TABLE 640 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 413 TABLE 641 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 642 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 643 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 644 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 645 REST OF EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 646 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 416 TABLE 647 REST OF EUROPE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 648 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 417 TABLE 649 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 417 TABLE 650 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 418 TABLE 651 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 418 TABLE 652 REST OF EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 653 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 419 TABLE 654 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 420 TABLE 655 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 422 TABLE 656 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 422 TABLE 657 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 658 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 659 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 660 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 661 ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 662 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 424 TABLE 663 ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 664 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 425 TABLE 665 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 426 TABLE 666 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 426 TABLE 667 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 427 TABLE 668 ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 427 TABLE 669 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 428 TABLE 670 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 428 TABLE 671 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 429 TABLE 672 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 673 CHINA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 674 CHINA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 675 CHINA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 676 CHINA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 677 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 431 TABLE 678 CHINA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 679 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 432 TABLE 680 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 433 TABLE 681 CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 433 TABLE 682 CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 683 CHINA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 684 CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 435 TABLE 685 CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 435 TABLE 686 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 437 TABLE 687 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 688 JAPAN: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 689 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 690 JAPAN: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 691 JAPAN: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 692 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 439 TABLE 693 JAPAN: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 694 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 440 TABLE 695 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 440 TABLE 696 JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 441 TABLE 697 JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 698 JAPAN: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 699 JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 442 TABLE 700 JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 443 TABLE 701 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 444 TABLE 702 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 703 INDIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 704 INDIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 705 INDIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 706 INDIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 707 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 446 TABLE 708 INDIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 709 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 447 TABLE 710 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 448 TABLE 711 INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 448 TABLE 712 INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 713 INDIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 714 INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 450 TABLE 715 INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 450 TABLE 716 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 451 TABLE 717 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 718 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 719 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 720 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 721 SOUTH KOREA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 722 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 453 TABLE 723 SOUTH KOREA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 724 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 454 TABLE 725 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 455 TABLE 726 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 455 TABLE 727 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 728 SOUTH KOREA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 729 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 457 TABLE 730 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 457 TABLE 731 AUSTRALIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 458 TABLE 732 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 733 AUSTRALIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 734 AUSTRALIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 735 AUSTRALIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 736 AUSTRALIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 737 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 460 TABLE 738 AUSTRALIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 739 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 461 TABLE 740 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 461 TABLE 741 AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 462 TABLE 742 AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 743 AUSTRALIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 463 TABLE 744 AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 463 TABLE 745 AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 464 TABLE 746 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 465 TABLE 747 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 748 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 749 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 750 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 751 REST OF ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 752 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 467 TABLE 753 REST OF ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 754 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 468 TABLE 755 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 468 TABLE 756 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 469 TABLE 757 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 469 TABLE 758 REST OF ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 759 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 470 TABLE 760 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 471 TABLE 761 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 472 TABLE 762 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 472 TABLE 763 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 764 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 765 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 766 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 767 LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 768 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 474 TABLE 769 LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 770 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 475 TABLE 771 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 476 TABLE 772 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 476 TABLE 773 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 774 LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 775 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 478 TABLE 776 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 478 TABLE 777 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 479 TABLE 778 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 479 TABLE 779 BRAZIL: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 780 BRAZIL: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 781 BRAZIL: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE , 2024–2031 (USD MILLION) 480 TABLE 782 BRAZIL: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 783 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 481 TABLE 784 BRAZIL: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 785 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 482 TABLE 786 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 483 TABLE 787 BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 483 TABLE 788 BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 789 BRAZIL: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 790 BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 485 TABLE 791 BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 485 TABLE 792 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 486 TABLE 793 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 794 MEXICO: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 795 MEXICO: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 796 MEXICO: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 797 MEXICO: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 798 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 488 TABLE 799 MEXICO: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 800 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 489 TABLE 801 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 490 TABLE 802 MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 490 TABLE 803 MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 804 MEXICO: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 805 MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 492 TABLE 806 MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 492 TABLE 807 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 493 TABLE 808 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 809 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 810 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 811 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 812 REST OF LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 813 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 495 TABLE 814 REST OF LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 815 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET , BY TECHNOLOGY, 2024–2031 (USD MILLION) 496 TABLE 816 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 497 TABLE 817 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 497 TABLE 818 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 819 REST OF LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 820 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 499 TABLE 821 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 499 TABLE 822 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION) 500 TABLE 823 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 501 TABLE 824 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 825 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 826 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 827 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 828 MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 829 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 503 TABLE 830 MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 831 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 504 TABLE 832 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 504 TABLE 833 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 505 TABLE 834 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 835 MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 836 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 506 TABLE 837 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 507 TABLE 838 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 508 TABLE 839 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 508 TABLE 840 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 841 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 842 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 843 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 844 GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 845 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 510 TABLE 846 GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 847 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 511 TABLE 848 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 512 TABLE 849 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 512 TABLE 850 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 851 GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 852 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 514 TABLE 853 GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 514 TABLE 854 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 515 TABLE 855 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 856 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 857 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 858 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 859 SAUDI ARABIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 860 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 517 TABLE 861 SAUDI ARABIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 862 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 518 TABLE 863 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 519 TABLE 864 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 519 TABLE 865 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 520 TABLE 866 SAUDI ARABIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 520 TABLE 867 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 521 TABLE 868 SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 521 TABLE 869 UAE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 522 TABLE 870 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 871 UAE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 872 UAE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 873 UAE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 874 UAE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 875 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 524 TABLE 876 UAE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 877 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 525 TABLE 878 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 526 TABLE 879 UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 526 TABLE 880 UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 527 TABLE 881 UAE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 527 TABLE 882 UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 528 TABLE 883 UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 528 TABLE 884 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 529 TABLE 885 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 529 TABLE 886 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 887 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 888 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 889 REST OF GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 890 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET , BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 531 TABLE 891 REST OF GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 892 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 532 TABLE 893 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 533 TABLE 894 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 533 TABLE 895 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 896 REST OF GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 897 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 535 TABLE 898 REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 535 TABLE 899 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 536 TABLE 900 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 536 TABLE 901 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 902 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 903 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 904 REST OF MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 905 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 538 TABLE 906 REST OF MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 907 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 539 TABLE 908 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 540 TABLE 909 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 540 TABLE 910 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 911 REST OF MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 912 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 542 TABLE 913 REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 542 TABLE 914 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 543 TABLE 915 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 916 AFRICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 917 AFRICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 918 AFRICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 545 TABLE 919 AFRICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 545 TABLE 920 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION) 545 TABLE 921 AFRICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 922 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 546 TABLE 923 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION) 547 TABLE 924 AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 547 TABLE 925 AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 548 TABLE 926 AFRICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 548 TABLE 927 AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION) 549 TABLE 928 AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 549 TABLE 929 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET 550 TABLE 930 IN VITRO TOXICOLOGY TESTING MARKET: DEGREE OF COMPETITION 554 TABLE 931 IN VITRO TOXICOLOGY TESTING MARKET: REGION FOOTPRINT (2025) 558 TABLE 932 IN VITRO TOXICOLOGY TESTING MARKET: OFFERING FOOTPRINT (2025) 559 TABLE 933 IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET: TECHNOLOGY FOOTPRINT (2025 560 TABLE 934 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 563 TABLE 935 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION 564 TABLE 936 IN VITRO TOXICOLOGY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 567 TABLE 937 HIGH-THROUGHPUT SCREENING MARKET: DEALS, JANUARY 2023–APRIL 2026 568 TABLE 938 HIGH-THROUGHPUT SCREENING MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026 568 TABLE 939 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 569 TABLE 940 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 570 TABLE 941 THERMO FISHER SCIENTIFIC INC: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 574 TABLE 942 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026 575 TABLE 943 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–APRIL 2026 575 TABLE 944 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 577 TABLE 945 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 578 TABLE 946 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023–APRIL 2026 580 TABLE 947 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026 581 TABLE 948 MERCK KGAA: COMPANY OVERVIEW 582 TABLE 949 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 583 TABLE 950 MERCK KGAA: DEALS, JANUARY 2023–APRIL 2026 585 TABLE 951 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 586 TABLE 952 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 587 TABLE 953 EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023–APRIL 2026 594 TABLE 954 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 595 TABLE 955 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 596 TABLE 956 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 600 TABLE 957 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2023–APRIL 2026 600 TABLE 958 CHARLES RIVER LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026 601 TABLE 959 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW 602 TABLE 960 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 603 TABLE 961 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2023–APRIL 2026 606 TABLE 962 LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2023–APRIL 2026 606 TABLE 963 LABORATORY CORPORATION OF AMERICA HOLDINGS: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026 607 TABLE 964 SGS SA: COMPANY OVERVIEW 608 TABLE 965 SGS SA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 609 TABLE 966 SGS SA: DEALS, JANUARY 2023–APRIL 2026 612 TABLE 967 SGS SA: EXPANSIONS, JANUARY 2023–APRIL 2026 612 TABLE 968 LONZA: COMPANY OVERVIEW 613 TABLE 969 LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 614 TABLE 970 REVVITY: COMPANY OVERVIEW 616 TABLE 971 REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 617 TABLE 972 REVVITY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 619 TABLE 973 REVVITY: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026 619 TABLE 974 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 620 TABLE 975 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 621 TABLE 976 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 623 TABLE 977 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023–APRIL 2026 624 TABLE 978 EVOTEC SE: COMPANY OVERVIEW 625 TABLE 979 EVOTEC SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 626 TABLE 980 EVOTEC SE: DEALS, JANUARY 2023–APRIL 2026 633 TABLE 981 LABORATORY CORPORATION OF AMERICA HOLDINGS: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026 633 TABLE 982 NOVO HOLDINGS: BUSINESS OVERVIEW 634 TABLE 983 INTERTEK GROUP PLC: BUSINESS OVERVIEW 635 TABLE 984 INOTIV: BUSINESS OVERVIEW 638 TABLE 985 PROMEGA CORPORATION: BUSINESS OVERVIEW 642 TABLE 986 PROMEGA CORPORATION: DEALS, JANUARY 2023–APRIL 2026 645 TABLE 987 BIOIVT: COMPANY OVERVIEW 646 TABLE 988 CREATIVE BIOLABS: COMPANY OVERVIEW 647 TABLE 989 MEDICILON: COMPANY OVERVIEW 648 TABLE 990 CREATIVE BIOARRAY: COMPANY OVERVIEW 649 TABLE 991 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW 650 TABLE 992 ENZO BIOCHEM INC.: COMPANY OVERVIEW 652 TABLE 993 MICROBAC LABORATORIES, INC.: COMPANY OVERVIEW 655 TABLE 994 VIMTA LABS LTD.: COMPANY OVERVIEW 657 TABLE 995 PACIFIC BIOLABS, INC.: COMPANY OVERVIEW 658 TABLE 996 MB RESEARCH LABORATORIES: COMPANY OVERVIEW 659 TABLE 997 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 668 FIGURE 1 MARKET SCENARIO 64 FIGURE 2 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, 2024–2031 65 FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET, 2023–2026 65 FIGURE 4 DISRUPTIONS INFLUENCING THE GROWTH OF IN VITRO TOXICOLOGY TESTING MARKET 66 FIGURE 5 HIGH-GROWTH SEGMENTS IN IN VITRO TOXICOLOGY TESTING MARKET, 2026–2031 67 FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 68 FIGURE 7 SHIFT TOWARDS NON-ANIMAL TOXICOLOGY TESTING METHODS TO DRIVE MARKET GROWTH 69 FIGURE 8 REAGENTS & CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET IN NORTH AMERICA IN 2025 70 FIGURE 9 ASIA PACIFIC IS LIKELY TO BE THE FASTEST-GROWING REGIONAL MARKET DURING THE FORECAST PERIOD 71 FIGURE 10 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 71 FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 72 FIGURE 12 IN VITRO TOXICOLOGY TESTING MARKET: PORTERS FIVE FORCES ANALYSIS 79 FIGURE 13 IN VITRO TOXICOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS 82 FIGURE 14 IN VITRO TOXICOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS 84 FIGURE 15 IN VITRO TOXICOLOGY TESTING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 88 FIGURE 16 TOP APPLICANTS/OWNERS (COMPANIES) FOR IN VITRO TOXICOLOGY TESTING PATENTS, 2015–2025 96 FIGURE 17 IMPACT OF AI/GEN AI ON IN VITRO TOXICOLOGY TESTING MARKET 98 FIGURE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 110 FIGURE 19 KEY BUYING CRITERIA, BY END USER 111 FIGURE 20 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 344 FIGURE 21 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 421 FIGURE 23 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2025 553 FIGURE 24 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 556 FIGURE 25 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY FOOTPRINT 557 FIGURE 26 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 562 FIGURE 27 EV/EBITDA OF KEY VENDORS 565 FIGURE 28 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 565 FIGURE 29 IN VITRO TOXICITY TESTING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 566 FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 570 FIGURE 31 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 578 FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2025) 583 FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 587 FIGURE 34 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025) 596 FIGURE 35 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2025) 603 FIGURE 36 SGS SA: COMPANY SNAPSHOT (2025) 609 FIGURE 37 LONZA: COMPANY SNAPSHOT (2025) 614 FIGURE 38 REVVITY: COMPANY SNAPSHOT (2025) 617 FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 621 FIGURE 40 EVOTEC SE: COMPANY SNAPSHOT (2025) 626 FIGURE 41 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2025) 636 FIGURE 42 INOTIV: COMPANY SNAPSHOT (2025) 639 FIGURE 43 RESEARCH DESIGN 660 FIGURE 44 IN VITRO TOXICOLOGY TESTING MARKET: BREAKDOWN OF PRIMARIES 662 FIGURE 45 IN VITRO TOXICOLOGY TESTING: MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025 663 FIGURE 46 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2025 664 FIGURE 47 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2025 664 FIGURE 48 IVTT MARKET: INSIGHTS FROM PRIMARIES 666 FIGURE 49 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 666 FIGURE 50 IN VITRO TOXICOLOGY TESTING MARKET: CAGR PROJECTIONS 668 FIGURE 51 IN VITRO TOXICOLOGY TESTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 669 FIGURE 52 DATA TRIANGULATION METHODOLOGY 670